| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.65B | 17.07B | 14.86B | 12.70B | 10.88B | 8.16B |
| Gross Profit | 11.97B | 11.59B | 9.79B | 8.69B | 7.35B | 5.60B |
| EBITDA | 4.41B | 4.37B | 3.42B | 3.59B | 3.01B | 1.76B |
| Net Income | 1.85B | 1.81B | 1.61B | 1.88B | 1.55B | 843.43M |
Balance Sheet | ||||||
| Total Assets | 16.66B | 17.31B | 15.20B | 13.53B | 12.05B | 9.74B |
| Cash, Cash Equivalents and Short-Term Investments | 4.87B | 5.93B | 5.32B | 4.91B | 4.39B | 3.51B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.86M |
| Total Liabilities | 3.47B | 4.09B | 3.58B | 2.97B | 2.91B | 1.76B |
| Stockholders Equity | 13.20B | 13.21B | 11.62B | 10.57B | 9.14B | 7.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.55B | 1.05B | 1.19B | 1.30B | 506.04M |
| Operating Cash Flow | 0.00 | 3.74B | 3.26B | 2.99B | 2.88B | 1.71B |
| Investing Cash Flow | 0.00 | -2.91B | -2.42B | -1.90B | -1.70B | -1.31B |
| Financing Cash Flow | 0.00 | -225.13M | -524.98M | -467.96M | -397.40M | -421.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥17.31B | 6.60 | ― | 3.62% | 7.07% | 79.18% | |
75 Outperform | ¥1.54T | 11.76 | 6.97% | 1.47% | 3.37% | -31.10% | |
74 Outperform | ¥1.45T | 11.67 | 6.28% | 1.07% | 3.01% | 6.48% | |
70 Outperform | ¥32.76B | 8.03 | ― | 1.72% | 23.94% | 47.11% | |
68 Neutral | ¥42.99B | 7.42 | ― | 3.71% | -0.04% | 93.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥115.47B | 18.97 | 19.59% | 0.16% | 18.08% | 136.77% |